Professor, Medicine, Tufts Medical Center
Cardiology
Dr. James E. Udelson, MD
|
|
Give Review
James Udelson practices Cardiology. He researched medicine at New York Medical College. He over the years received 3 awards: "Boston Magazine", "CMS Meaningful Use Stage 1 Certification" and "Fellow (FACC)". James Udelson has written publications. He has 99 publications published with PubMed. The lastest publication is: 'Use of Coronary Computed Tomographic Angiography Findings to Modify Statin and Aspirin Prescription in Patients With Acute Chest Pain.' He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Use of Coronary Computed Tomographic Angiography Findings to Modify Statin and Aspirin Prescription in Patients With Acute Chest Pain.
- hs-Troponin I Followed by CT Angiography Improves Acute Coronary Syndrome Risk Stratification Accuracy and Work-Up in Acute Chest Pain Patients: Results From ROMICAT I...
- Sensitive troponin assays in patients with suspected Acute coronary syndrome: Results from the multicenter rule out myocardial infarction using computer assisted tomog...
- Use of coronary artery calcium scanning beyond coronary computed tomographic angiography in the emergency department evaluation for Acute chest pain: the ROMICAT II tr...
- Outcomes of Anatomical versus Functional Testing for Coronary Artery Disease.
- Early resting myocardial computed tomography perfusion for the detection of Acute coronary syndrome in patients with coronary artery disease.
- Significance of left ventricular apical-basal muscle bundle identified by cardiovascular magnetic resonance imaging in patients with hypertrophic Cardiomyopathy.
- Advanced Heart Failure with Preserved Systolic Function in Nonobstructive Hypertrophic Cardiomyopathy: Under-Recognized Subset of Candidates for Heart Transplant.
- One-Year Outcomes of Out-of-Hospital Administration of Intravenous Glucose, Insulin, and Potassium (GIK) in Patients With Suspected Acute Coronary Syndromes (from the ...
- Contemporary Surgical Management of Hypertrophic Cardiomyopathy, the Need for More Myectomy Surgeons and Disease-Specific Centers, and the Tufts Initiative.
- Sex differences in the effectiveness of early coronary computed tomographic angiography compared with standard emergency department evaluation for Acute chest pain: th...
- Risk stratification and outcome of patients with hypertrophic Cardiomyopathy >=60 years of age.
- Phase II Safety and Clinical Comparison With Single-Photon Emission Computed Tomography Myocardial Perfusion Imaging for Detection of Coronary Artery Disease: Flurpiri...
- Influence of documented history of coronary artery disease on outcomes in patients admitted for worsening Heart failure with reduced ejection fraction in the EVEREST t...
- Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of Heart failure with reduced ejection ...
- Comparing prognostic value of imaging agents and imaging techniques.
- Coronary CT angiography versus standard evaluation in Acute chest pain.
- Significance of False Negative Electrocardiograms in Preparticipation Screening of Athletes for Hypertrophic Cardiomyopathy.
- What Is the "Goal" Serum Potassium Level in Acute Myocardial Infarction?
- Out-of-Hospital Administration of Intravenous Glucose-Insulin-Potassium in Patients With Suspected Acute Coronary Syndromes: The IMMEDIATE Randomized Controlled Trial.
- Design of the Rule Out Myocardial Ischemia/Infarction Using Computer Assisted Tomography: a multicenter randomized comparative effectiveness trial of cardiac computed ...
- 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy A Report of the American College of Cardiology Foundation/American Heart Associa...
- 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary A Report of the American College of Cardiology Foundation/Ame...
- Intermediate Signal Intensity Late Gadolinium Enhancement Predicts Ventricular TachyArrhythmias in Patients with Hypertrophic Cardiomyopathy.
- A Multicenter, Randomized, Double-blind, Placebo-controlled Study of Tolvaptan Monotherapy Compared to Furosemide and the Combination of Tolvaptan and Furosemide in Pa...
- 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology Foundation/Am...
- 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology Foundation/American Heart Associ...
- T.M.I. (Too Much Information)?
- Drug and Device Effects on Peak Oxygen Consumption, 6 Minute Walk Distance, and Natriuretic Peptides as Predictors of Therapeutic Effects on Mortality in Patients with...
- Mitral Valve Abnormalities Identified by Cardiovascular Magnetic Resonance Represent a Primary Phenotypic Expression of Hypertrophic Cardiomyopathy.
- The ninth annual Mario S. Verani memorial lecture : Testing our tests: The evidence bar is rising. Regulatory considerations in the development of cardiac imaging agents.
- Effects of tolvaptan on physician-assessed symptoms and signs in patients hospitalized with acute Heart failure syndromes: Analysis from the Efficacy of Vasopressin An...
- Advancing the research mission of ASNC.
- Ventricular remodeling fundamental to the progression (and regression) of Heart failure.
- The Occluded Artery Trial (OAT) Viability Ancillary Study (OAT-NUC): Influence of infarct zone viability on left ventricular remodeling after percutaneous Coronary int...
- Influence of myocardial ischemia on outcomes in patients with systolic versus non-systolic Heart failure.
- Left ventricular remodeling in Heart failure: current concepts in clinical significance and assessment.
- Survival after cardiac transplantation in patients with hypertrophic Cardiomyopathy.
- Quantitative evaluation of drug or device effects on ventricular remodeling as predictors of therapeutic effects on mortality in patients with Heart failure and reduce...
- Iodofiltic acid I 123 (BMIPP) fatty acid imaging improves initial diagnosis in emergency department patients with suspected Acute coronary syndromes: a multicenter trial.
- Spectrum and clinical significance of systolic function and myocardial fibrosis assessed by cardiovascular magnetic resonance in hypertrophic Cardiomyopathy.
- Randomized, double-blind, multicenter, placebo-controlled study evaluating the effect of aldosterone antagonism with eplerenone on ventricular remodeling in patients w...
- Gated SPECT myocardial perfusion imaging for the prediction of incident Heart failure an old dog learns a new trick.
- The case for myocardial ischemia in hypertrophic Cardiomyopathy.
- Hypertrophic Cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance.
- Adherence with once daily versus twice daily carvedilol in patients with Heart failure: the Compliance And Quality of Life Study Comparing Once-Daily Controlled-Releas...
- Coronary computed tomography angiography for early triage of patients with Acute chest pain: the ROMICAT (Rule Out Myocardial Infarction using Computer Assisted Tomogr...
- Etiology and pathophysiology of new-onset Heart failure: evaluation by myocardial perfusion imaging.
- Influence of donor cocaine use on outcome after cardiac transplantation: analysis of the United Network for Organ Sharing Thoracic Registry.
- Acute hemodynamic effects of tolvaptan, a vasopressin V2 receptor blocker, in patients with symptomatic Heart failure and systolic dysfunction: an international, multi...
- Continental differences in clinical characteristics, management, and outcomes in patients hospitalized with worsening Heart failure results from the EVEREST (Efficacy ...
- Prevalence, clinical significance, and natural history of left ventricular apical Aneurysms in hypertrophic cardiomyopathy.
- Assessment and key targets for therapy in the post-Myocardial infarction patient with left ventricular dysfunction.
- Clinical profile and significance of delayed enhancement in hypertrophic Cardiomyopathy.
- Design, rationale, and populations of an international outcomes and utilization study of pharmacologic stress SPECT Myocardial perfusion imaging in contemporary practice.
- Assessment and significance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic Cardiomyopathy.
- Arginine vasopressin antagonists for the treatment of Heart failure and hyponatremia.
- The inaugural issue of Circulation: Heart Failure.
- Lessons from the development of new adenosine A2A receptor agonists.
- Occurrence and frequency of Arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance.
- Significance of papillary muscle abnormalities identified by cardiovascular magnetic resonance in hypertrophic Cardiomyopathy.
- Imaging highlights from the European Society of Cardiology, American Society of Nuclear Cardiology, and Heart Failure Society of America.
- Eighth Nuclear Cardiology Invitational Conference Park City, Utah, 2006.
- Right ventricular involvement in hypertrophic Cardiomyopathy.
- Intramyocardial transplantation of autologous CD34+ stem cells for intractable Angina: a phase I/IIa double-blind, randomized controlled trial.
- Multicenter, randomized, double-blind, placebo-controlled study on the effect of oral tolvaptan on left ventricular dilation and function in patients with Heart failur...
- Future directions of Myocardial fatty acid imaging.
- The price for probability: Comparing the costs of diagnostic testing strategies.
- Hypertrophic cardiomyopathy is predominantly a Disease of left ventricular outflow tract obstruction.
- Vascular endothelial dysfunction is associated with reversible myocardial perfusion defects in the absence of obstructive Coronary artery disease.
- Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic Cardiomyopathy.
- A head-to-head comparison of infusion and bolus doses of adenosine for stress Myocardial contrast echocardiography.
- Overview of vasopressin receptor antagonists in Heart failure resulting in hospitalization.
- Hyponatremia in patients with Heart failure.
- Gender-based differences in brachial artery flow-mediated vasodilation as an indicator of significant Coronary artery disease.
- Metabolic imaging with beta-methyl-p-[(123)I]-iodophenyl-pentadecanoic acid identifies ischemic memory after demand ischemia.
- Gender-related differences in the clinical presentation and outcome of hypertrophic Cardiomyopathy.
- Significance and relation between magnitude of left ventricular hypertrophy and Heart failure symptoms in hypertrophic cardiomyopathy.
- Ventricular assist device therapy normalizes inducible nitric oxide synthase expression and reduces cardiomyocyte apoptosis in the failing human Heart.
- Rationale and design of the multicenter, randomized, double-blind, placebo-controlled study to evaluate the Efficacy of Vasopressin antagonism in Heart Failure: Outcom...
- Task Force 4: HCM and other cardiomyopathies, mitral valve prolapse, myocarditis, and Marfan Syndrome.
- Novel neurohormonal antagonist strategies: vasopressin antagonism, anticytokine therapy, and endothelin antagonism in patients who have Heart failure.
- Screening the population for Coronary artery disease: is it like screening for cancer?
- Quantitative instruments for predicting risk ... and benefit.
- Randomized, controlled evaluation of short- and long-term benefits of Heart failure disease management within a diverse provider network: the SPAN-CHF trial.
- Acute resting myocardial perfusion imaging in patients with diabetes mellitus: results from the Emergency Room Assessment of Sestamibi for Evaluation of Chest Pain (ER...
- Ventricular remodeling in Heart failure and the effect of beta-blockade.
- Prognostic and therapeutic implications of myocardial viability in patients with Heart failure.
- The historical and conceptual evolution of radionuclide assessment of Myocardial viability.
- Randomized, controlled dose-ranging study of the selective adenosine A2A receptor agonist binodenoson for pharmacological stress as an adjunct to Myocardial perfusion ...
- Ventricular remodeling in Heart failure: a credible surrogate endpoint.
- Assessment of peripheral vascular endothelial function with finger arterial pulse wave amplitude.
- Primary prevention of sudden death as a novel treatment strategy in hypertrophic Cardiomyopathy.
- 34th Bethesda Conference: Executive summary--can atherosclerosis imaging techniques improve the detection of patients at risk for ischemic Heart disease?
- Peripheral vascular endothelial function correlates with exercise capacity in cardiac transplant recipients.
- MIBG imaging for selecting Heart failure patients for defibrillator therapy: a first step.
- New concepts in post-Infarction ventricular remodeling.
- Myocardial perfusion imaging for evaluation and triage of patients with suspected Acute cardiac ischemia: a randomized controlled trial.
Schools
New York Medical College
Newton Wellesley Hospital
NhlbiNih
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- View All
Conditions Treated
- Aneurysm and Dissection of Heart
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Dissection
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
Awards
- Boston Magazine
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACC)
Education
-
Tufts Medical Center -
New York Medical College
Hospital
-
Tufts Medical Center
Drug Facts
| NPI NUMBER | 1164469813 | |
| NPPES Provider LastName | UDELSON | |
| NPPES Provider FirstName | JAMES | |
| NPPES Provider ZIPCode | 021111526 | |
| NPPES Provider State | MA | |
| Specialty Description | Cardiology | |
| Total Claim Count | 213.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1164469813 |
| Last Name Of The Provider | UDELSON |
| First Name Of The Provider | JAMES |
| View All |
Similar Doctors
|
|
Dr. Viviany R. Taqueti, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dabit Arzamendi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Zena Hassan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Yuval Konstantino, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joshua A. Beckman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Evan Appelbaum, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dominic J. Allocco, MD |
|
|
Dr. Neil J. Wimmer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brendan M. Everett, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeremy N. Ruskin, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Mandeep R. Mehra, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jennifer L. Giuseffi, MD
This Doctor is OpenDoctor Recommended.
|